Ep 21: Andy Coravos and Ashoka Rajendra on Hyperspecialization in Pharma R&D and Digital Biomarkers

from Vital Signs with Jacob Effron and Nikhil Krishnan · host Redpoint Ventures

Jacob sits down with HumanFirst CEO Andy Coravos and Orchestra CEO Ashoka Rajendra to discuss at home data collection in trials, Andy being an EIR at the FDA, why Benchling has been so successful and more.

Episode metadata supplied by the publisher feed · Published Apr 25, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Ep 21: Andy Coravos and Ashoka Rajendra on Hyperspecialization in Pharma R&D and Digital Biomarkers

0:00 42:22

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Vital Signs with Jacob Effron and Nikhil Krishnan?

This episode is 42 minutes long.

When was this Vital Signs with Jacob Effron and Nikhil Krishnan episode published?

This episode was published on April 25, 2023.

Can I download this Vital Signs with Jacob Effron and Nikhil Krishnan episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!